Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Synthetic Biology Market Size to Reach USD 87 Billion in 2030 | Emergen Research

This image opens in the lightbox

News provided by

Emergen Research

06 Feb, 2023, 18:00 GMT

Share this article

Share toX

Share this article

Share toX

VANCOUVER, BC, Feb. 6, 2023 /PRNewswire/ -- The synthetic biology market size reached USD 10.35 Billion in 2021 and is expected to register a CAGR of 26.7% during the forecast period, according to latest analysis by Emergen Research. Rising research and development activities in this field of synthetic biology, growing application of synthetic biology including living biotherapeutics, multiplexed diagnostics, and third-generation biorefineries as well rising investments towards synthetic biology start-ups developing tools and services are some key factors driving synthetic biology market revenue growth.


The area of synthetic biology is growing rapidly and uses engineering and scientific principles in the design and management of living systems, enabling technological advancements that may have a large impact on the global economy. This technology is being used by producers to more efficiently create high-performance and ecologically friendly products, which is boosting market revenue growth. The development of sophisticated genome editing techniques like CRISPR/Cas9, as well as advancements in informatics, computational tools, and facilities to facilitate and scale analysis and design, have all helped to significantly lower the price of DNA synthesis and sequencing.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1556

Synthetic biology techniques have already been utilized to alter human cells to treat diseases and alter microbes to manufacture important substances for the industry. Startups in synthetic biology are developing more environmentally friendly products that utilize less water and land and don't rely on fossil fuels or their byproducts. Additionally, these products are generally healthier for people and more long-lasting, producing less trash after use, which is contributing significantly to the growth of this industry.

Drivers:

Demand for synthetic biology devices has significantly increased over the years due to rising investments in synthetic biology start-ups developing tools and services. Over the past ten years, more than 12 billion dollars have been invested in the synthetic biology industry. This includes around USD 4 billion in 2019, with a major amount of funding coming from renowned biotechnology firms like Bayer and Novartis, strong investment organizations like SoftBank, DCVC, and a16z, and startup accelerators Y Combinator and IndieBio. Major startups and corporations are developing a wide range of products leveraging the synthetic biology technique, which is driving the market's growth. For instance, on July 29, 2022, German corporation Insempra, which uses biology to empower businesses to generate superior goods by collaborating with nature, announced a strategic investment in synthetic biology company Solena Materials. The Solena firm develops high-performance textile fibers for clothing. Furthermore, significant companies that offer synthetic biology as a service are only now beginning to emerge on the market. Three of them, Ginkgo Bioworks, Zymergen, and Twist Bioscience, offered outsourcing services for the creation of genetically modified organisms and nucleic acids for different applications. Some companies, including Synthace and Teselagen Biotechnology, have created AI-powered tools to efficiently construct DNA/RNA sequences.

Restraints:

There are some issues and difficulties facing the synthetic biology industry. One of the significant challenges hindering the growth of this industry is the significant biosafety risk in synthetic biology is the intentional or unintentional release of synthetic organisms into the environment during experiments and other activities. Synthetic microbes and bacteria have the potential to evolve and interact with other organisms, contaminating the environment. They may also breed with local species, upset ecosystems, or lead to the formation of superbugs resistant to antibiotics. In addition, engineers working in synthetic biology face ethical issues that go beyond those encountered in other technical fields, which is hindering the growth of synthetic biology market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1556

Growth Projections:

The synthetic biology market is expected to register a CAGR of 26.7% over the forecast period and revenue is projected to increase from USD 10.35 Billion in 2021 to USD 87 Billion in 2030. Increasing spending in emerging markets is expected to support revenue growth of the market.

Current Trends and Innovations:

The industry is undergoing gradual change as a result of rapid technological advancements as well as growing demand for engineered living biotherapeutics. Synthetic biology technologies are evolving, with the potential to make practically anything competitively and sustainably. This industry is growing at a significant rate because companies are adopting synthetic biology methods to develop innovative products and processes, enhance existing operations, and cut costs in order to stay competitive in the future. New advancements in bacterial and mammalian cell construction include the creation of cells that operate in biological materials or within the body as minimally invasive theranostics for the real-time regulation of complicated pathological states. A major upgrade in the field of theranostic cell engineering was FDA approval of tisagenlecleucel (Kymriah), the first gene therapy to be authorized in the United States. In this type of gene therapy, CAR-T cells are created by separating patient T cells, genetically altering them to express a chimeric antigen receptor (CAR), and then bringing back them into the patient, where they can survive for years or decades. As a result, Synthetic Biology is more in demand in the medical sector, which is boosting the growth of this market.

Strategic Initiatives:

Major companies included in the market report are Amyris, Inc., Ginkgo Bioworks, Novozymes AG, Synbio Technologies, Evonetix Ltd., Calyxt, Inc., Codex DNA, Inc., GenScript Corporation., Twist Biosciences, and Eurofins Scientific, Inc.

  • On 12 August 2021, Antheia, a synthetic biology business that enables the development of future plant-inspired drugs, and Ginkgo Bioworks, which is constructing the top horizontal platform for cell programming, announced a collaboration to quicken the discovery and manufacturing of critical drugs. Ginkgo assists clients from a variety of industries looking to create new and improved products. It recently announced a business merger with Soaring Eagle Acquisition Corp. Antheia intends to increase the number of essential active pharmaceutical ingredients (APIs) and important starting materials in its pipeline by utilizing Ginkgo's high throughput enzyme design and screening capabilities (KSMs).

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/synthetic-biology-market

Scope of Research

Report Details

Outcome

Market size in 2021

USD 10.35 Billion

CAGR (2022–2030)

26.7 %

Revenue forecast to 2030

USD 87 Billion

Base year for estimation

2021

Historical data

2019–2020

Forecast period

2022–2030

Quantitative units

Revenue in USD Million and CAGR in % from 2022 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product Type, Technology, Application, End-Use, and region

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Country scope

U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA

Key companies profiled

Amyris, Inc., Ginkgo Bioworks, Novozymes AG, Synbio Technologies, Evonetix Ltd., Calyxt, Inc., Codex DNA, Inc., GenScript Corporation., Twist Biosciences, and Eurofins Scientific, Inc.

Customization scope

10 hours of free customization and expert consultation


Custom Requirements can be requested for this Report [Customization Available] @
https://www.emergenresearch.com/request-for-customization/1556

Emergen Research has segmented synthetic biology market on the basis of product, technology, application, end-use, and region:

  • Product Outlook (Revenue, USD Billion; 2019-2030)
    • Synthetic DNA and Oligonucleotides
    • Enzymes
    • Synthetic Cells
    • Chassis Organisms
    • Xeno-nucleic acids
    • Others
  • Technology Outlook (Revenue, USD Billion; 2019-2030)
    • Gene Synthesis
    • Site-directed Mutagenesis
    • Cloning
    • Bioinformatics
    • Nucleotide Sequencing
    • Microfluidics
    • Others
  • Application Outlook (Revenue, USD Billion; 2019-2030)
    • Medical & Healthcare
      • Drug delivery & therapeutics
      • Diagnostics
      • Pharmaceuticals
    • Tissue Regeneration
    • Environment & Agriculture
    • Bioprocess Technology
    • Others
  • End-Use Outlook (Revenue, USD Billion; 2019-2030)
    • Pharmaceutical & Biotechnology Companies
    • Clinical & Diagnostic Laboratories
    • Academic Research Institutions
  • Regional Outlook (Revenue, USD Billion, 2019 - 2030)
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • South Korea
      • India
      • Australia
      • Rest of APAC
    • Latin America
      • Brazil
      • Mexico
      • Rest of LATAM
    • Middle East & Africa
      • UAE
      • Saudi Arabia
      • Africa
      • Rest of Middle East

Latest Research Reports Published by Emergen Research:

Gas Treatment Market, By Type (Amines and Non-Amines), By Application (Dehydration and Acid Gas Removal), and By Region Forecast to 2030

Flight Simulator Market, By Method (Synthetic and Virtual), By Type (Flight Training Devices, Full Flight Simulators, Full Mission Flight Simulators, and Fixed Base Simulators), By Platform (Commercial and Military), and By Region Forecast to 2030

Electronic Flight Instrument System Market, By Platform (Commercial Aviation, Military Aviation, and General Aviation), By Application By Fit (Line-Fit and Retrofit), and By Region Forecast to 2030

Space Cryogenics Market By Cooling Type (High Temperature and Low Temperature Coolers), By Component Type (Low Conductive Supports, Multilayer Insulation, V-Groove Shields), By Application and By Region Forecast to 2030

Smart Shelves Market By Component (Hardware, Software & Solutions, and Professional Services), By Organization Size (Large Enterprises and Small & Medium-Sized Enterprises), By Application, and By Region Forecast to 2030

Connected Toys Market, By Application (Education and Entertainment), By Age Group (1-5 Years, 6-8 Years, 9-12 Years, and Teenagers (13-19 Years)), By Distribution Channel (Online and Offline), and By Region Forecast to 2030

Negative Pressure Wound Therapy Market, By Product Type (Conventional NPWT, Single-Use NPWT, and Accessories), By Wound Type, By End-Use, and By Region Forecast to 2030

Hypercholesterolemia Market, By Disease Type (Genetic and Acquired), By Treatment Type (Statins, Bile-acid Binding Resins, Niacin, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), By Region Forecast to 2030

About Emergen Research 

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read our Press Release @ https://www.emergenresearch.com/press-release/global-synthetic-biology-market
Trending Titles LiDAR Market | Metaverse Market

Logo: https://mma.prnewswire.com/media/1579538/Emergen_Research_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.